NORD

Nordicus Partners Corp

3.38

Nov 02 • 11:39 AM ET -1.54 (-31.29%)

Healthcare Biotechnology USA Micro NASD

Today, 9:31 AMNo clear catalyst identified for NORD 27% overnight drop holding at the open

Index	-
Market Cap	65.62M
Enterprise Value	65.61M
Income	-5.07M
Sales	0.00M
Book/sh	3.21
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Apr 24, 2020
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Jun 12, 1996

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.05
P/C	6562.42
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.18
Current Ratio	0.18
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-0.27
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	75.08% 47.92%
Sales past 3/5Y	- -
EPS Y/Y TTM	19.52%
Sales Y/Y TTM	-100.00%
EPS Q/Q	-70.20%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	66.79%
Insider Trans	0.00%
Inst Own	0.00%
Inst Trans	-
ROA	-6.80%
ROE	-8.06%
ROIC	-8.23%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-16.88%
SMA50	-6.22%
SMA200	-15.13%
Trades

Shs Outstand	19.17M
Shs Float	6.46M
Short Float	-
Short Ratio	-
Short Interest	-
52W High	5.15 -34.47%
52W Low	1.48 128.04%
Volatility	17.86% 8.60%
ATR (14)	0.47
RSI (14)	42.96
Beta	-1.34
Rel Volume	6.28
Avg Volume	7.42K
Volume	17,552

Perf Week	-15.62%
Perf Month	-15.81%
Perf Quarter	50.00%
Perf Half Y	-5.21%
Perf YTD	-32.50%
Perf Year	-32.50%
Perf 3Y	-57.81%
Perf 5Y	-66.67%
Perf 10Y	54.06%
Recom	-
Target Price	-
Prev Close	4.91
Price	3.38
Change %	-31.29%

Nordicus Partners Corp. is a biotech company, which specializes in developing breakthrough therapeutics in diseases with unmet medical needs. It focuses on acquisition and development of drugs from innovative biotech companies in the Nordics. The company was founded on April 7, 1993 and is headquartered in Beverly Hills, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NORD

Nordicus Partners Corp

Upgrade your Finviz experience